Prevalence of FGIDs and Probiotics Study

Launched by CHULALONGKORN UNIVERSITY · Mar 6, 2024

Keywords

ClinConnect Summary

The Prevalence of FGIDs and Probiotics Study is a research trial aimed at understanding how common Functional Gastrointestinal Disorders (FGIDs) are in infants and whether a specific probiotic, Limosilactobacillus reuteri DSM 17938, can help prevent these disorders. FGIDs can cause uncomfortable symptoms like tummy aches and irregular bowel movements in babies. The study uses a questionnaire to gather information about these conditions in infants and is currently looking for participants.

Eligible participants are healthy infants between 3 days to 1 year old, born at full term, and showing normal development. Their mothers should not have used probiotics before the study. If you choose to participate, you will be asked to attend follow-up appointments over the course of the year to monitor your baby's health. This study could help improve understanding and prevention of gastrointestinal issues in infants, benefiting many families in the future.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • 1. Healthy and term (GA 37-41 weeks) infants
• • 2. Appropriate weight for age
• • 3. APGAR score more than 8 at 10 minutes of life
• • 4. Normal physical examination
• • 5. Mothers have no previous probiotics use
• Exclusion Criteria:
• • 1. not willing to anticipate in the study
• • 2. cannot come to follow-up until 1 year of age